Dissection of the human antibody response to the malaria antigen Pf155/RESA into epitope specific components.
about
Molecular cloning and characterisation of the RESA gene, a marker of genetic diversity of Plasmodium falciparumIsolation of peptides that mimic epitopes on a malarial antigen from random peptide libraries displayed on phage.Isolation and serological characterization of a Plasmodium vivax recombinant antigen.IgG isotypic antibodies to crude Plasmodium falciparum blood-stage antigen associated with placental malaria infection in parturient Cameroonian womenAntigen-specific influence of GM/KM allotypes on IgG isotypes and association of GM allotypes with susceptibility to Plasmodium falciparum malaria.Production by activated human T cells of interleukin 4 but not interferon-gamma is associated with elevated levels of serum antibodies to activating malaria antigens.Structural and antigenic properties of merozoite surface protein 4 of Plasmodium falciparum.High immunoglobulin G2 (IgG2) and low IgG4 levels are associated with human resistance to Plasmodium falciparum malaria.Familial correlation of immunoglobulin G subclass responses to Plasmodium falciparum antigens in Burkina Faso.Neonatal infections in Saudi Arabia: association with C-reactive protein, CRP -286 (C>T>A) gene polymorphism and IgG antibodiesAnti-idiotypic antibodies counteract the invasion inhibition capacity of antibodies to major epitopes of the Plasmodium falciparum antigen Pf155/RESA.Number of cells from Plasmodium falciparum-immune donors that produce gamma interferon in vitro in response to Pf155/RESA, a malaria vaccine candidate antigenDeterminants of infant susceptibility to malaria during the first year of life in South Western cameroonCellular and humoral immune responses to well-defined blood stage antigens (major merozoite surface antigen) of Plasmodium falciparum in adults from an Indian zone where malaria is endemic.Immunoglobulin response to Plasmodium falciparum RESA proteins in uncomplicated and severe malaria.Genetic regulation of human anti-malarial antibodies in twins.Immunogenicity and antigenicity in rabbits of a repeated sequence of Plasmodium falciparum antigen Pf155/RESA fused to two immunoglobulin G-binding domains of staphylococcal protein A.FcgammaRIIa (CD32) polymorphism and anti-malarial IgG subclass pattern among Fulani and sympatric ethnic groups living in eastern Sudan.Cytokine profiles and antibody responses to Plasmodium falciparum malaria infection in individuals living in Ibadan, southwest Nigeria.Characteristic age distribution of Plasmodium vivax infections after malaria elimination on Aneityum Island, Vanuatu.Immunological characteristics of hyperreactive malarial splenomegaly syndrome in sudanese patients.Human antibody response to the major merozoite surface antigen of Plasmodium falciparum is strain specific and short-lived.Passive immunization of Aotus monkeys with human antibodies to the Plasmodium falciparum antigen Pf155/RESA.Febrile status, malarial parasitaemia and gastro-intestinal helminthiases in schoolchildren resident at different altitudes, in south-western Cameroon.Antibodies that protect humans against Plasmodium falciparum blood stages do not on their own inhibit parasite growth and invasion in vitro, but act in cooperation with monocytes.Inhibition of in vitro growth of plasmodium falciparum field isolates mediated by human antibodies to Pf155/RESA and Pf332.Comparison of the number of IL-4 and IFN-gamma secreting cells in response to the malaria vaccine candidate antigen Pf155/RESA in two groups of naturally primed individuals living in a malaria endemic area in Burkina Faso.The multifactorial and multistage character of protective immunity to Plasmodium falciparum, naturally acquired by an indigenous population in Burkina Faso.Antibodies to a non-repeat region of Plasmodium falciparum antigen Pf155/RESA in individuals from malaria-endemic areas.Pattern of pre-existing IgG subclass responses to a panel of asexual stage malaria antigens reported during the lengthy dry season in Daraweesh, Sudan.Antibodies to Pf155/RESA and circumsporozoite protein of Plasmodium falciparum in paired maternal-cord sera from Nigeria.Association between immune recognition of the malaria vaccine candidate antigen Pf155/RESA and resistance to clinical disease: a prospective study in a malaria-endemic region of west Africa.Fc gamma receptor IIa (CD32) polymorphism and antibody responses to asexual blood-stage antigens of Plasmodium falciparum malaria in Sudanese patients.Potentiation of immune response against the RESA peptides of Plasmodium falciparum by incorporating a universal T-cell epitope (CS.T3) and an immunomodulator (polytuftsin), and delivery through liposomes.Epitopes of the Plasmodium falciparum clustered-asparagine-rich protein (CARP) recognized by human T-cells and antibodies.Sera of patients with systemic lupus erythematosus react with plasmodial antigens and can inhibit the in vitro growth of Plasmodium falciparum.Cytoadherence-related homologous motifs in Plasmodium falciparum antigen Pf155/RESA and erythrocyte band 3 protein.A malaria serological map indicating the intersection between parasite antigenic diversity and host antibody repertoires.
P2860
Q27972723-6F847F63-1D68-4D8B-9392-F0924A28069FQ30756827-D0F89C0E-E651-4108-8AAB-38B5B2CA7606Q33550482-D52DCAD0-D396-4F74-A6C3-A15924FAA315Q33584320-8E864E35-EA04-4134-B098-28C7352DE85CQ33587436-2ED8A86B-87DB-4C81-8513-4363348F624CQ33698157-5E9AF64F-F5E9-458D-98E8-3DCBD4FE84C2Q33866986-1E4B3586-DC7C-4046-9FA6-4620EB278A0BQ34003525-50839C9F-BCA2-4EFC-9EA1-5ED54C694FDCQ34006021-5E7D8BCF-BC74-4841-9729-E7FB72E33090Q34939198-3B7328AC-CEF7-4016-8EDF-1ED773543050Q35103469-F9FFAC21-542F-432B-B6FA-14F5B7446C05Q35104314-2AF56617-F494-4195-B50A-E60ABAA28F2EQ35628255-47315F87-EBC1-41EB-9B4A-3A9FA5DB4BFAQ35773738-9653401B-FAB8-4EF8-9B06-434C60EDAC0DQ35852373-3859B60E-62BE-44B4-8ED4-385969D8FDF1Q36881319-FD1324A1-DD33-4FB9-8B0C-4006D9A8CDA4Q36978970-16163CDA-91E7-4B30-90C9-8F5A72EAD473Q37139274-001F78FD-18B3-4733-8A0D-38EC8A84EB99Q37253603-B2182081-81AD-4B29-B739-62687CB7216CQ37548182-EFD9812B-3679-435B-A78E-2EEEC4A1D98CQ38869373-43CBCB37-594C-44AF-B59D-366A54BF9D7FQ40150215-6F62576F-5B1D-4EA8-8123-C6D979C67032Q40150313-819F7064-E78F-4412-A241-031EADB387F2Q40425459-29F6D88E-0D05-49B5-BC5A-B89C6BB7509DQ42938913-1D387054-4812-4F37-B418-3BCCBCF6C7DCQ43935070-5094F937-31F1-4A1A-95B5-F55AB890DA59Q43935734-18E70C54-3B95-4089-A055-4E00D946AE53Q43935921-B874B8D9-72BE-4FDF-8EC2-C82FE77B9A7CQ43952316-C9274930-9357-4B1F-B735-F127E215D4BAQ46537309-6D47AFCF-782F-48F3-AACF-9166AA3EE357Q46704949-BCDADFDE-624C-496C-AE76-13D9E40FF4ADQ46726426-D1B31D68-2BB7-43D4-9DAA-E9F5D1906567Q47836433-4DF1A78C-AB42-4AA7-8441-0C75590D661BQ47853144-74877F98-FBE5-4CD5-AAAA-B4E3CFAD7230Q47864360-7D5B429E-A397-4FB9-83C0-297A7B0850D8Q47910742-522267E9-91BC-4C63-8DC1-39AA4866255CQ48000947-716025DC-7CC8-4A46-A94E-D9CA3DD422CCQ48013786-4F88E994-B3B4-4CCD-B384-7D3700D6E309
P2860
Dissection of the human antibody response to the malaria antigen Pf155/RESA into epitope specific components.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Dissection of the human antibo ...... o epitope specific components.
@en
type
label
Dissection of the human antibo ...... o epitope specific components.
@en
prefLabel
Dissection of the human antibo ...... o epitope specific components.
@en
P2093
P2860
P1476
Dissection of the human antibo ...... o epitope specific components.
@en
P2093
Andersson I
Björkman A
Hagstedt M
Perlmann H
Petersen E
P2860
P304
P356
10.1111/J.1600-065X.1989.TB00555.X
P577
1989-12-01T00:00:00Z